A brain stem infarction occurs when the brain stem tissue is prevented from receiving blood due to a stroke, which can result in very rapid cell death, brain damage, and even death. Damage or blockage to the carotid arteries yields a cerebral brain infarction, affecting the cerebral cortex, while damage to the vertebral arteries leads to a brain stem infarction, affecting the lower portion of the brain. Symptoms of a brain stem infarction are consistent with those of a stroke and can include dizziness, numbness, motor skill and vision impairment, headaches, and nausea. People who are at a higher risk for brain stem infarctions include those who have high cholesterol and are at risk for blood clots as well as those with a genetic disposition for strokes. Treatments for brain stem infarctions focus on increasing blood flow to the affected area as quickly as possible, as cells can die without oxygen and nutrients from blood in a matter of minutes.
Brain Stem Infarctions Bioinformatics Tool
Laverne is a handy bioinformatics tool to help facilitate scientific exploration of related genes, diseases and pathways based on co-citations. Explore more on Brain Stem Infarctions below!
For more information on how to use Laverne, please read the How to Guide.
We have 1188 products for the study of Brain Stem Infarctions that can be applied to Western Blot, Chromatin Immunoprecipitation, Flow Cytometry, Immunohistochemistry, Immunocytochemistry/Immunofluorescence, Chromatin Immunoprecipitation (ChIP) from our catalog of antibodies and ELISA kits.
Brain Stem Infarctions is also known as Brain Stem Infarct, Brain Stem Infarction, Brain Stem Stroke, Brainstem Infarction, Brainstem Infarctions.
PRODUCT AVAILABILITY: Update Regarding the Evolving COVID-19 Situation
Bio-Techne appreciates the critical role that you and our products and services play in research efforts to further scientific innovation and discovery. We are continually assessing our manufacturing and supplier capabilities during the COVID-19 situation and are implementing precautionary measures to ensure uninterrupted supply of products and services. Currently, and as we abide by local shelter in place orders across the world, we are fully operational and do not anticipate any material supply disruptions across our Bio-Techne brands and product lines. As the situation evolves, our goal is to utilize preventive measures to reduce the threat that COVID-19 poses to our ability to meet the needs of our customers globally.